CN110272502A - 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 - Google Patents
免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 Download PDFInfo
- Publication number
- CN110272502A CN110272502A CN201910629767.3A CN201910629767A CN110272502A CN 110272502 A CN110272502 A CN 110272502A CN 201910629767 A CN201910629767 A CN 201910629767A CN 110272502 A CN110272502 A CN 110272502A
- Authority
- CN
- China
- Prior art keywords
- cardiac muscle
- polypeptide
- muscle troponin
- monoclonal antibody
- troponin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010065729 Troponin I Proteins 0.000 title claims abstract description 101
- 102000013394 Troponin I Human genes 0.000 title claims abstract description 101
- 210000003205 muscle Anatomy 0.000 title claims abstract description 46
- 210000004408 hybridoma Anatomy 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 230000028327 secretion Effects 0.000 title claims abstract description 25
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 94
- 229920001184 polypeptide Polymers 0.000 claims abstract description 89
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 89
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 6
- 210000004165 myocardium Anatomy 0.000 claims description 58
- 238000001514 detection method Methods 0.000 claims description 53
- 239000003153 chemical reaction reagent Substances 0.000 claims description 26
- 210000004027 cell Anatomy 0.000 claims description 23
- 238000012360 testing method Methods 0.000 claims description 17
- 241001465754 Metazoa Species 0.000 claims description 16
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 210000002966 serum Anatomy 0.000 claims description 12
- 230000008878 coupling Effects 0.000 claims description 10
- 238000010168 coupling process Methods 0.000 claims description 10
- 238000005859 coupling reaction Methods 0.000 claims description 10
- 238000012216 screening Methods 0.000 claims description 10
- 230000002163 immunogen Effects 0.000 claims description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- 239000011575 calcium Substances 0.000 claims description 8
- 210000004988 splenocyte Anatomy 0.000 claims description 8
- 102000014914 Carrier Proteins Human genes 0.000 claims description 7
- 108010078791 Carrier Proteins Proteins 0.000 claims description 7
- 230000003248 secreting effect Effects 0.000 claims description 6
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 5
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 5
- 102100034613 Annexin A2 Human genes 0.000 claims description 4
- 108090000668 Annexin A2 Proteins 0.000 claims description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 4
- 229940098773 bovine serum albumin Drugs 0.000 claims description 4
- 108060003552 hemocyanin Proteins 0.000 claims description 4
- 108010088751 Albumins Proteins 0.000 claims description 3
- 102000009027 Albumins Human genes 0.000 claims description 3
- 102000008946 Fibrinogen Human genes 0.000 claims description 3
- 108010049003 Fibrinogen Proteins 0.000 claims description 3
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 claims description 3
- 229940012952 fibrinogen Drugs 0.000 claims description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 235000013601 eggs Nutrition 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 13
- 150000001413 amino acids Chemical group 0.000 description 34
- 101100537532 Rattus norvegicus Tnni3 gene Proteins 0.000 description 29
- 239000000427 antigen Substances 0.000 description 24
- 102000036639 antigens Human genes 0.000 description 24
- 108091007433 antigens Proteins 0.000 description 24
- 102000004903 Troponin Human genes 0.000 description 20
- 108090001027 Troponin Proteins 0.000 description 20
- 238000000034 method Methods 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 238000004020 luminiscence type Methods 0.000 description 9
- 238000002965 ELISA Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000002671 adjuvant Substances 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 238000002649 immunization Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002872 contrast media Substances 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000006249 magnetic particle Substances 0.000 description 5
- RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 206010003445 Ascites Diseases 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 101000851334 Homo sapiens Troponin I, cardiac muscle Proteins 0.000 description 3
- 101710128251 Troponin I, cardiac muscle Proteins 0.000 description 3
- 102100036859 Troponin I, cardiac muscle Human genes 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000012772 sequence design Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 108090000362 Lymphotoxin-beta Proteins 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000013534 Troponin C Human genes 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000011888 autopsy Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 229940092253 ovalbumin Drugs 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- MDNAVFBZPROEHO-DCAQKATOSA-N Ala-Lys-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MDNAVFBZPROEHO-DCAQKATOSA-N 0.000 description 1
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 1
- KQBVNNAPIURMPD-PEFMBERDSA-N Asp-Ile-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KQBVNNAPIURMPD-PEFMBERDSA-N 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000007590 Calpain Human genes 0.000 description 1
- 108010032088 Calpain Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- GCYFUZJHAXJKKE-KKUMJFAQSA-N Glu-Arg-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GCYFUZJHAXJKKE-KKUMJFAQSA-N 0.000 description 1
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- QHGBCRCMBCWMBJ-UHFFFAOYSA-N Ile-Glu-Ala-Lys Natural products CCC(C)C(N)C(=O)NC(CCC(O)=O)C(=O)NC(C)C(=O)NC(C(O)=O)CCCCN QHGBCRCMBCWMBJ-UHFFFAOYSA-N 0.000 description 1
- WBSCNDJQPKSPII-KKUMJFAQSA-N Lys-Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O WBSCNDJQPKSPII-KKUMJFAQSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- JWQWPTLEOFNCGX-AVGNSLFASA-N Phe-Glu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JWQWPTLEOFNCGX-AVGNSLFASA-N 0.000 description 1
- UAJAYRMZGNQILN-BQBZGAKWSA-N Ser-Gly-Met Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O UAJAYRMZGNQILN-BQBZGAKWSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000004987 Troponin T Human genes 0.000 description 1
- 108090001108 Troponin T Proteins 0.000 description 1
- VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 1
- BMGOFDMKDVVGJG-NHCYSSNCSA-N Val-Asp-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BMGOFDMKDVVGJG-NHCYSSNCSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- -1 acridine ester Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003452 antibody preparation method Methods 0.000 description 1
- 108010084758 arginyl-tyrosyl-aspartic acid Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- BPYKTIZUTYGOLE-UHFFFAOYSA-N billirubin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(C=C3C(=C(C=C)C(=O)N3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011697 sodium iodate Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910629767.3A CN110272502B (zh) | 2019-07-12 | 2019-07-12 | 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910629767.3A CN110272502B (zh) | 2019-07-12 | 2019-07-12 | 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110272502A true CN110272502A (zh) | 2019-09-24 |
CN110272502B CN110272502B (zh) | 2021-09-14 |
Family
ID=67964312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910629767.3A Active CN110272502B (zh) | 2019-07-12 | 2019-07-12 | 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110272502B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110878296A (zh) * | 2019-10-16 | 2020-03-13 | 武汉伊莱瑞特生物科技股份有限公司 | 一种高敏hrp酶及其制备方法与应用 |
CN111077320A (zh) * | 2019-12-27 | 2020-04-28 | 河北省科学院生物研究所 | 一种检测鸡或鸭骨骼肌肌钙蛋白i的酶联免疫试剂盒及其制备方法与应用 |
CN111735960A (zh) * | 2019-12-10 | 2020-10-02 | 华南农业大学 | 一种禽类肺动脉高压诊断试剂盒的制备方法 |
CN111925432A (zh) * | 2020-08-18 | 2020-11-13 | 杭州启泰生物技术有限公司 | 一种心肌肌钙蛋白i重组抗原及其单克隆抗体的制备方法 |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054218A1 (en) * | 1997-05-29 | 1998-12-03 | Medical Analysis Systems Inc. | Troponin i forms and use of same |
CN1259524A (zh) * | 1999-11-12 | 2000-07-12 | 清华大学 | 用表位多肽诱导/制备表位特异性的单克隆抗体的方法 |
CN1314363A (zh) * | 2000-03-21 | 2001-09-26 | 南京医科大学第一附属医院 | 人体心肌肌钙蛋白i的纯化和其单克隆抗体的制备及其快速测定的方法 |
US20030040024A1 (en) * | 1996-06-25 | 2003-02-27 | Katrukha Alex G. | Method and kit for the diagnosis of troponin I |
CN1660893A (zh) * | 2004-12-23 | 2005-08-31 | 复旦大学 | 一种人心肌肌钙蛋白i合成肽段s28-42及其用途 |
CN1982337A (zh) * | 2005-12-14 | 2007-06-20 | 中国医学科学院放射医学研究所 | 抗人心肌肌钙蛋白i合成多肽抗体及其制备方法与应用 |
CN101105497A (zh) * | 2006-07-13 | 2008-01-16 | 上海凯创生物技术有限公司 | 一种检测心肌肌钙蛋白i的试剂盒及其制备方法 |
WO2009118185A1 (en) * | 2008-03-27 | 2009-10-01 | Universitätsklinikum Heidelberg | Peptides derived from cardial troponin i and their use as prognostic and diagnostic markers for heart failure |
CN101942416A (zh) * | 2010-07-23 | 2011-01-12 | 中国医学科学院放射医学研究所 | 抗人心肌肌钙蛋白i特异性单克隆抗体及其制备方法 |
CN102725633A (zh) * | 2009-12-03 | 2012-10-10 | 雅培制药有限公司 | 用于诊断心肌细胞损害的测定 |
CN103173420A (zh) * | 2013-04-08 | 2013-06-26 | 深圳市菲鹏生物股份有限公司 | 可分泌抗心肌肌钙蛋白i单抗的杂交瘤细胞及应用 |
CN104020289A (zh) * | 2014-06-23 | 2014-09-03 | 宁波艾科生物科技有限公司 | 一种筛选抗原不同结合位点的单克隆抗体的方法 |
CN204165984U (zh) * | 2014-10-28 | 2015-02-18 | 广州天宝颂原生物科技开发有限公司 | 心肌肌钙蛋白i免疫层析定量检测试纸条 |
CN104833798A (zh) * | 2015-04-27 | 2015-08-12 | 杭州金溪生物技术有限公司 | 基于均相化学发光技术的快速诊断试纸条 |
CN104991077A (zh) * | 2015-07-29 | 2015-10-21 | 安徽省煦棠医疗科技有限公司 | 肌钙蛋白i竞争比浊法检测试剂盒 |
CN105132383A (zh) * | 2015-07-25 | 2015-12-09 | 大庆麦伯康生物技术有限公司 | 抗cTnI单克隆抗体产生的杂交瘤 |
CN105567719A (zh) * | 2016-01-06 | 2016-05-11 | 北京嘉万生物技术有限公司 | cTnⅠ主要表位区的重组表达及其抗体的制备方法 |
CN107422129A (zh) * | 2017-01-15 | 2017-12-01 | 北京科跃中楷生物技术有限公司 | 一种超敏的心肌肌钙蛋白i磁微球免疫比浊检测方法及检测试剂盒 |
CN107677833A (zh) * | 2017-09-21 | 2018-02-09 | 苏州新波生物技术有限公司 | 一种心肌肌钙蛋白i磁微粒化学发光测定试剂盒及其使用方法 |
CN109709323A (zh) * | 2019-02-15 | 2019-05-03 | 深圳上泰生物工程有限公司 | 高敏心肌肌钙蛋白i磁微粒化学发光免疫检测试剂盒、制备方法及用途 |
CN109912713A (zh) * | 2019-01-08 | 2019-06-21 | 美康生物科技股份有限公司 | 用于免疫诊断试剂配制的肌钙蛋白i抗体的制备方法及获得的菌株 |
-
2019
- 2019-07-12 CN CN201910629767.3A patent/CN110272502B/zh active Active
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030040024A1 (en) * | 1996-06-25 | 2003-02-27 | Katrukha Alex G. | Method and kit for the diagnosis of troponin I |
WO1998054218A1 (en) * | 1997-05-29 | 1998-12-03 | Medical Analysis Systems Inc. | Troponin i forms and use of same |
CN1259524A (zh) * | 1999-11-12 | 2000-07-12 | 清华大学 | 用表位多肽诱导/制备表位特异性的单克隆抗体的方法 |
CN1314363A (zh) * | 2000-03-21 | 2001-09-26 | 南京医科大学第一附属医院 | 人体心肌肌钙蛋白i的纯化和其单克隆抗体的制备及其快速测定的方法 |
CN1660893A (zh) * | 2004-12-23 | 2005-08-31 | 复旦大学 | 一种人心肌肌钙蛋白i合成肽段s28-42及其用途 |
CN1982337A (zh) * | 2005-12-14 | 2007-06-20 | 中国医学科学院放射医学研究所 | 抗人心肌肌钙蛋白i合成多肽抗体及其制备方法与应用 |
CN101105497A (zh) * | 2006-07-13 | 2008-01-16 | 上海凯创生物技术有限公司 | 一种检测心肌肌钙蛋白i的试剂盒及其制备方法 |
WO2009118185A1 (en) * | 2008-03-27 | 2009-10-01 | Universitätsklinikum Heidelberg | Peptides derived from cardial troponin i and their use as prognostic and diagnostic markers for heart failure |
CN102725633A (zh) * | 2009-12-03 | 2012-10-10 | 雅培制药有限公司 | 用于诊断心肌细胞损害的测定 |
CN101942416A (zh) * | 2010-07-23 | 2011-01-12 | 中国医学科学院放射医学研究所 | 抗人心肌肌钙蛋白i特异性单克隆抗体及其制备方法 |
CN103173420A (zh) * | 2013-04-08 | 2013-06-26 | 深圳市菲鹏生物股份有限公司 | 可分泌抗心肌肌钙蛋白i单抗的杂交瘤细胞及应用 |
CN104020289A (zh) * | 2014-06-23 | 2014-09-03 | 宁波艾科生物科技有限公司 | 一种筛选抗原不同结合位点的单克隆抗体的方法 |
CN204165984U (zh) * | 2014-10-28 | 2015-02-18 | 广州天宝颂原生物科技开发有限公司 | 心肌肌钙蛋白i免疫层析定量检测试纸条 |
CN104833798A (zh) * | 2015-04-27 | 2015-08-12 | 杭州金溪生物技术有限公司 | 基于均相化学发光技术的快速诊断试纸条 |
CN105132383A (zh) * | 2015-07-25 | 2015-12-09 | 大庆麦伯康生物技术有限公司 | 抗cTnI单克隆抗体产生的杂交瘤 |
CN104991077A (zh) * | 2015-07-29 | 2015-10-21 | 安徽省煦棠医疗科技有限公司 | 肌钙蛋白i竞争比浊法检测试剂盒 |
CN105567719A (zh) * | 2016-01-06 | 2016-05-11 | 北京嘉万生物技术有限公司 | cTnⅠ主要表位区的重组表达及其抗体的制备方法 |
CN107422129A (zh) * | 2017-01-15 | 2017-12-01 | 北京科跃中楷生物技术有限公司 | 一种超敏的心肌肌钙蛋白i磁微球免疫比浊检测方法及检测试剂盒 |
CN107677833A (zh) * | 2017-09-21 | 2018-02-09 | 苏州新波生物技术有限公司 | 一种心肌肌钙蛋白i磁微粒化学发光测定试剂盒及其使用方法 |
CN109912713A (zh) * | 2019-01-08 | 2019-06-21 | 美康生物科技股份有限公司 | 用于免疫诊断试剂配制的肌钙蛋白i抗体的制备方法及获得的菌株 |
CN109709323A (zh) * | 2019-02-15 | 2019-05-03 | 深圳上泰生物工程有限公司 | 高敏心肌肌钙蛋白i磁微粒化学发光免疫检测试剂盒、制备方法及用途 |
Non-Patent Citations (6)
Title |
---|
GUY MOLTU J.等: "The Impact of Antibody Selection on the Detection of Cardiac Troponin I", 《CLINICA CHIMICA ACTA》 * |
LIN YIXIN等: "Development of a Qualitative Sequential Immunoassay for Characterizing the Intrinsic Properties of Circulating Cardiac Troponin I", 《CLINICAL CHEMISTRY》 * |
SAVUKOSKI TANJA等: "Epitope Specificity and IgG Subclass Distribution of Autoantibodies to Cardiac Troponin", 《CLINICAL CHEMISTRY》 * |
中华医学会微生物与免疫学分会,军事医学科学院微生物流行病研究所: "《第六次全国医学分子微生物学及生物技术研讨会论文集》", 31 August 2006 * |
焦宝明等: "人心肌肌钙蛋白I单克隆抗体的制备及鉴定", 《第二军医大学学报》 * |
程敏卓等: "基于光激化学发光技术开发的多表位检测cTnI的方法", 《免疫学杂志》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110878296A (zh) * | 2019-10-16 | 2020-03-13 | 武汉伊莱瑞特生物科技股份有限公司 | 一种高敏hrp酶及其制备方法与应用 |
CN110878296B (zh) * | 2019-10-16 | 2021-11-30 | 武汉伊莱瑞特生物科技股份有限公司 | 一种高敏hrp酶及其制备方法与应用 |
CN111735960A (zh) * | 2019-12-10 | 2020-10-02 | 华南农业大学 | 一种禽类肺动脉高压诊断试剂盒的制备方法 |
CN111077320A (zh) * | 2019-12-27 | 2020-04-28 | 河北省科学院生物研究所 | 一种检测鸡或鸭骨骼肌肌钙蛋白i的酶联免疫试剂盒及其制备方法与应用 |
CN111077320B (zh) * | 2019-12-27 | 2023-06-16 | 河北省科学院生物研究所 | 一种检测鸡或鸭骨骼肌肌钙蛋白i的酶联免疫试剂盒及其制备方法与应用 |
CN111925432A (zh) * | 2020-08-18 | 2020-11-13 | 杭州启泰生物技术有限公司 | 一种心肌肌钙蛋白i重组抗原及其单克隆抗体的制备方法 |
CN111925432B (zh) * | 2020-08-18 | 2024-01-19 | 杭州启泰生物技术有限公司 | 一种心肌肌钙蛋白i重组抗原及其单克隆抗体的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110272502B (zh) | 2021-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110272502A (zh) | 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 | |
RU2315773C2 (ru) | Специфические антитела для диагностики сердечной недостаточности | |
CN111217907B (zh) | 抗amh单克隆抗体及其应用 | |
CN113248590B (zh) | 一种NT-proBNP蛋白抗原决定簇多肽及其应用 | |
CN113637081B (zh) | 一株分泌抗二甲戊灵单克隆抗体的杂交瘤细胞株及其应用 | |
CN109596839A (zh) | 人和肽素快速定量检测方法与试剂盒 | |
CN110092824B (zh) | 氨基末端脑钠肽前体多肽、抗体及其制备方法、检测试剂盒及检测方法 | |
JP3107225B2 (ja) | Pacapに対する抗体およびその用途 | |
CN105606814B (zh) | 检测人ApoE‑ε4蛋白的荧光免疫层析试纸及其制备方法 | |
CN110183530A (zh) | 瘦素免疫原、杂交瘤细胞、单克隆抗体、多克隆抗体及应用 | |
Groome et al. | Preparation and properties of monoclonal antibodies to myelin basic protein and its peptides | |
CA1338782C (en) | Antibodies for use in determining human glycoalbumin | |
CN109705221B (zh) | C肽免疫原及其单克隆抗体对及该抗体对在c肽磁微粒化学发光免疫试剂中的应用 | |
CN110275014B (zh) | 一种术中快速鉴别甲状腺乳头状癌颈淋巴结转移的方法 | |
CA1334176C (en) | Monoclonal antibody recognizing gamma atrial natriuretic polypeptide | |
CN114478716A (zh) | 一种多肽组合及其在新型冠状病毒抗体检测中的应用 | |
CN108752480B (zh) | 一种免疫原组合物、其制备方法及其用途 | |
Erhard et al. | Identification of antigenic differences of recombinant and pituitary bovine growth hormone using monoclonal antibodies | |
CN1195069C (zh) | 人卵泡刺激素β亚基单克隆抗体的制备方法 | |
CN105669835B (zh) | 人ApoE-ε4抗原表位肽、抗原、抗体、应用及试剂盒 | |
CN114805589B (zh) | 可同时识别牛、山羊、绵羊抗体的单克隆抗体 | |
CN110317254A (zh) | 人mbp抗原表位肽、抗原、抗体、应用及化学发光试剂盒 | |
CN117024595B (zh) | 抗人st2的单克隆抗体及其应用 | |
CN112592398B (zh) | 一种bnp抗原决定簇多肽及其应用 | |
CN110317246A (zh) | 人mog抗原表位肽、抗原、抗体、应用及化学发光试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221226 Address after: 518116 Yahui Long Biotechnology Plant, Baolong Street, Longgang District, Shenzhen City, Guangdong Province Patentee after: SHENZHEN YHLO BIOTECH Co.,Ltd. Patentee after: Shenzhen Zhuoren Biotechnology Co.,Ltd. Address before: 518116 Yahui Long Biotechnology Plant, Baolong Street, Longgang District, Shenzhen City, Guangdong Province Patentee before: SHENZHEN YHLO BIOTECH Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240311 Address after: 518116 Yahui Long Biotechnology Plant, Baolong Street, Longgang District, Shenzhen City, Guangdong Province Patentee after: SHENZHEN YHLO BIOTECH Co.,Ltd. Country or region after: China Address before: 518116 Yahui Long Biotechnology Plant, Baolong Street, Longgang District, Shenzhen City, Guangdong Province Patentee before: SHENZHEN YHLO BIOTECH Co.,Ltd. Country or region before: China Patentee before: Shenzhen Zhuoren Biotechnology Co.,Ltd. |